Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7125)
All Articles published online
|
Mar 27, 2013 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cacciapuoti F, Scognamiglio A, Palumbo R, Forte R, Cacciapuoti F. Silymarin in non alcoholic fatty liver disease. World J Hepatol 2013; 5(3): 109-113 [PMID: 23556042 DOI: 10.4254/wjh.v5.i3.109] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v5/i3/109.htm |
| Number | Citing Articles |
| 1 |
Xin Wang, Yufeng Jin, Can Di, Yupeng Zeng, Yuqing Zhou, Yu Chen, Zhijun Pan, Zhongxia Li, Wenhua Ling. Supplementation of Silymarin Alone or in Combination with Salvianolic Acids B and Puerarin Regulates Gut Microbiota and Its Metabolism to Improve High-Fat Diet-Induced NAFLD in Mice. Nutrients 2024; 16(8): 1169 doi: 10.3390/nu16081169
|
| 2 |
Sheng Zhong, Yuxiang Fan, Qi Yan, Xingyu Fan, Bo Wu, Yujuan Han, Ying Zhang, Yong Chen, Huimao Zhang, Junqi Niu. The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease. Medicine 2017; 96(49): e9061 doi: 10.1097/MD.0000000000009061
|
| 3 |
Noel Salvoza, Pablo J. Giraudi, Claudio Tiribelli, Natalia Rosso. Natural Compounds for Counteracting Nonalcoholic Fatty Liver Disease (NAFLD): Advantages and Limitations of the Suggested Candidates. International Journal of Molecular Sciences 2022; 23(5): 2764 doi: 10.3390/ijms23052764
|
| 4 |
Tingting Yan, Nana Yan, Ping Wang, Yangliu Xia, Haiping Hao, Guangji Wang, Frank J. Gonzalez. Herbal drug discovery for the treatment of nonalcoholic fatty liver disease. Acta Pharmaceutica Sinica B 2020; 10(1): 3 doi: 10.1016/j.apsb.2019.11.017
|
| 5 |
Bo Zhang, Fang Ding, Tian Chen, Liang-Hua Xia, Juan Qian, Guo-Yi Lv. Ultrasound hepatic/renal ratio and hepatic attenuation rate for quantifying liver fat content. World Journal of Gastroenterology 2014; 20(47): 17985-17992 doi: 10.3748/wjg.v20.i47.17985
|
| 6 |
Devaraj Ezhilarasan, Thangavelu Lakshmi, Ramoji Kosuru. A Molecular Insight into the Role of Antioxidants in Nonalcoholic Fatty Liver Diseases. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/9233650
|
| 7 |
Jayagopalan Veena, Anjaneyulu Muragundla, Srinivas Sidgiddi, Swaminathan Subramaniam. Non-alcoholic fatty liver disease: need for a balanced nutritional source. British Journal of Nutrition 2014; 112(11): 1858 doi: 10.1017/S0007114514002591
|
| 8 |
M. Kasi Reddy, A. Gopala Reddy, B. Kala Kumar, D. Madhuri, G. Boobalan, M. Anudeep Reddy. Protective effect of rutin in comparison to silymarin against induced hepatotoxicity in rats. Veterinary World 2017; 10(1): 74 doi: 10.14202/vetworld.2017.74-80
|
| 9 |
Amera Abd El Latif, Doaa H. Assar, Ebtihal M. Elkaw, Hanafy A. Hamza, Dalal Hussien M. Alkhalifah, Wael N. Hozzein, Ragaa A. Hamouda. Protective role of Chlorella vulgaris with Thiamine against Paracetamol induced toxic effects on haematological, biochemical, oxidative stress parameters and histopathological changes in Wistar rats. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83316-8
|
| 10 |
Samah M. El Sohafy, Aly M. Metwally, Abdalla A. Omar, Masouda E. Amer, Mohamed M. Radwan, Maged S. Abdel-Kader, Sayed A. El Toumy, Mahmoud A. ElSohly. Cornigerin, a new sesqui-lignan from the hepatoprotective fractions of Cynara cornigera L. Fitoterapia 2016; 115: 101 doi: 10.1016/j.fitote.2016.09.015
|
| 11 |
Eudmar Marcolino Assis-Júnior, Anielle Torres Melo, Venúcia Bruna Magalhães Pereira, Deysi Viviana Tenazoa Wong, Nathalia Ribeiro Pinho Sousa, Christiane Mendes Gonçalves Oliveira, Lara Raissa Cavalcante Malveira, Leonardo Silva Moreira, Marcellus Henrique Loiola Ponte Souza, Paulo Roberto Carvalho Almeida, Roberto César Pereira Lima-Júnior. Dual effect of silymarin on experimental non-alcoholic steatohepatitis induced by irinotecan. Toxicology and Applied Pharmacology 2017; 327: 71 doi: 10.1016/j.taap.2017.04.023
|
| 12 |
Marinko Marušić, Matej Paić, Mia Knobloch, Ana-Marija Liberati Pršo, Branka Filipović. NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/6613827
|
| 13 |
Halil Beydilli, Nigar Yilmaz, Esin Sakalli Cetin, Yasar Topal, Ozgur Ilhan Celik, Cem Sahin, Hatice Topal, Ibrahim Hakki Cigerci, Hamdi Sozen. Evaluation of the Protective Effect of Silibinin Against Diazinon Induced Hepatotoxicity and Free-Radical Damage in Rat Liver. Iranian Red Crescent Medical Journal 2015; 17(4) doi: 10.5812/ircmj.17(4)2015.25310
|
| 14 |
Hager H. Shaaban, Ibrahim Alzaim, Ahmed El-Mallah, Rania G. Aly, Ahmed F. El-Yazbi, Ahmed Wahid. Metformin, pioglitazone, dapagliflozin and their combinations ameliorate manifestations associated with NAFLD in rats via anti-inflammatory, anti-fibrotic, anti-oxidant and anti-apoptotic mechanisms. Life Sciences 2022; 308: 120956 doi: 10.1016/j.lfs.2022.120956
|
| 15 |
Hironori Kitade, Guanliang Chen, Yinhua Ni, Tsuguhito Ota. Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments. Nutrients 2017; 9(4): 387 doi: 10.3390/nu9040387
|
| 16 |
Yuan XIE, Hai-Ping HAO, Hong WANG, Zhao-Xian WANG, Guang-Ji WANG. Reversing effects of silybin on TAA-induced hepatic CYP3A dysfunction through PXR regulation. Chinese Journal of Natural Medicines 2013; 11(6): 645 doi: 10.1016/S1875-5364(13)60075-8
|
| 17 |
Thabani Mpanza, Myalowenkosi I. Sabela, Sanele S. Mathenjwa, Suvardhan Kanchi, Krishna Bisetty. Electrochemical Determination of Capsaicin and Silymarin Using a Glassy Carbon Electrode Modified by Gold Nanoparticle Decorated Multiwalled Carbon Nanotubes. Analytical Letters 2014; 47(17): 2813 doi: 10.1080/00032719.2014.924010
|
| 18 |
Qiang Ou, Yuanyuan Weng, Siwei Wang, Yajuan Zhao, Feng Zhang, Jianhua Zhou, Xiaolin Wu. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway. Digestive Diseases and Sciences 2018; 63(12): 3398 doi: 10.1007/s10620-018-5268-0
|
| 19 |
Kaan Demiroren, Mehmet Turan Basunlu, Remzi Erten, Erdem Cokluk. A comparison of the effects of thymoquinone, silymarin and N-acetylcysteine in an experimental hepatotoxicity. Biomedicine & Pharmacotherapy 2018; 106: 1705 doi: 10.1016/j.biopha.2018.07.125
|
| 20 |
Ali Kemal Onalan, Salih Tuncal, Sibel Kilicoglu, Salih Celepli, Esra Durak, Bulent Kilicoglu, Erdinc Devrim, Aziz Mutlu Barlas, Kemal Kismet. Effect of sılymarın on oxıdatıve stress and lıver hıstopathology ın experımental obstructıve jaundıce model. Acta Cirurgica Brasileira 2016; 31(12): 801 doi: 10.1590/s0102-865020160120000004
|
| 21 |
Sean P. Tighe, Daud Akhtar, Umair Iqbal, Aijaz Ahmed. Chronic Liver Disease and Silymarin: A Biochemical and Clinical Review. Journal of Clinical and Translational Hepatology 2020; 8(4): 1 doi: 10.14218/JCTH.2020.00012
|
| 22 |
Licia Polimeni, Maria Del Ben, Francesco Baratta, Ludovica Perri, Fabiana Albanese, Daniele Pastori, Francesco Violi, Francesco Angelico. Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis. World Journal of Hepatology 2015; 7(10): 1325-1336 doi: 10.4254/wjh.v7.i10.1325
|
| 23 |
Kasi Pandima Devi. Nonvitamin and Nonmineral Nutritional Supplements. 2019; : 321 doi: 10.1016/B978-0-12-812491-8.00046-1
|
| 24 |
Paola Nogueira Coutinho, Beatriz Peters Pereira, Ana Claudia Hertel Pereira, Marcella Leite Porto, Arícia Leone Evangelista Monteiro de Assis, Afrânio Côgo Destefani, Silvana Santos Meyrelles, Elisardo Corral Vasquez, Breno Valentim Nogueira, Tadeu Uggere de Andrade, Denise Coutinho Endringer, Marcio Fronza, Thiago Melo Costa Pereira. Chronic administration of antioxidant resin from Virola oleifera attenuates atherogenesis in LDLr -/- mice. Journal of Ethnopharmacology 2017; 206: 65 doi: 10.1016/j.jep.2017.05.015
|
| 25 |
Michal Bijak, Ewelina Synowiec, Przemyslaw Sitarek, Tomasz Sliwiński, Joanna Saluk-Bijak. Evaluation of the Cytotoxicity and Genotoxicity of Flavonolignans in Different Cellular Models. Nutrients 2017; 9(12): 1356 doi: 10.3390/nu9121356
|
| 26 |
Jean M. Bokelmann. Medicinal Herbs in Primary Care. 2022; : 495 doi: 10.1016/B978-0-323-84676-9.00061-1
|
| 27 |
Shagufta Akhtar, Azhar Khan. Analysis of Metabolic Biomarkers in Non-Alcoholic Fatty Liver Disease (NAFLD); A Comprehensive Review. Advanced Journal of Graduate Research 2020; 9(1): 46 doi: 10.21467/ajgr.9.1.46-58
|
| 28 |
Sepide Amini, Mohammad Bagherniya, Alexandra E. Butler, Gholamreza Askari, Amirhossein Sahebkar. The effect of medicinal plants on cirrhosis: A systematic review of clinical trials. Phytotherapy Research 2023; 37(7): 3083 doi: 10.1002/ptr.7816
|
| 29 |
Ali Taghipour, Fatemeh Ghaffarifar, John Horton, Abdolhossein Dalimi, Zohreh Sharifi. Silybum marianum ethanolic extract: in vitro effects on protoscolices of Echinococcus granulosus G1 strain with emphasis on other Iranian medicinal plants. Tropical Medicine and Health 2021; 49(1) doi: 10.1186/s41182-021-00363-7
|
| 30 |
Hamdi Sozen, Ozgür Ilhan Celik, Esin Sakalli Cetin, Nigar Yilmaz, Alper Aksozek, Yasar Topal, Ibrahim Hakkı Cigerci, Halil Beydilli. Evaluation of the Protective Effect of Silibinin in Rats with Liver Damage Caused by Itraconazole. Cell Biochemistry and Biophysics 2015; 71(2): 1215 doi: 10.1007/s12013-014-0331-8
|
| 31 |
Hao Chen, Tong Nie, Penglu Zhang, Jun Ma, Anshan Shan. Hesperidin attenuates hepatic lipid accumulation in mice fed high-fat diet and oleic acid induced HepG2 via AMPK activation. Life Sciences 2022; 296: 120428 doi: 10.1016/j.lfs.2022.120428
|
| 32 |
Xin Wen, Yidi Peng, Bohao Zheng, Shaying Yang, Jing Han, Fan Yu, Tingting Zhou, Li Geng, Zhiming Yu, Lei Feng. Silybin induces endothelium-dependent vasodilation via TRPV4 channels in mouse mesenteric arteries. Hypertension Research 2022; 45(12): 1954 doi: 10.1038/s41440-022-01000-4
|
| 33 |
Gülen Arslan Lied, Odd Helge Gilja, Trygve Hausken. Har silibinin en plass i behandlingen av leversykdommer?. Tidsskrift for Den norske legeforening 2014; 134(4): 392 doi: 10.4045/tidsskr.13.1531
|
| 34 |
Navaneethakrishnan Polachi, Guirong Bai, Tingyang Li, Yang Chu, Xiangyang Wang, Shuming Li, Ning Gu, Jiang Wu, Wei Li, Yanjun Zhang, Shuiping Zhou, He Sun, Changxiao Liu. Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer – A comprehensive review. European Journal of Medicinal Chemistry 2016; 123: 577 doi: 10.1016/j.ejmech.2016.07.070
|
| 35 |
Chan Wah Kheong, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis. Clinical Gastroenterology and Hepatology 2017; 15(12): 1940 doi: 10.1016/j.cgh.2017.04.016
|
| 36 |
Manuel Suárez, Noemí Boqué, Josep del Bas, Jordi Mayneris-Perxachs, Lluís Arola, Antoni Caimari. Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease. Nutrients 2017; 9(10): 1052 doi: 10.3390/nu9101052
|
| 37 |
Ernesto Calderon Martinez, Domenica Herrera, Saruveish Mogan, Zainab Hameed, Ayesha Altaf Jangda, Tayyaba J Khan, Palvi Mroke, Samar Sajid, Yash R Shah, Imran Baig. Impact of Silymarin Supplements on Liver Enzyme Levels: A Systematic Review. Cureus 2023; doi: 10.7759/cureus.47608
|
| 38 |
Aleksandra Kołota, Dominika Głąbska. Dietary Intake of Milk Thistle Seeds as a Source of Silymarin and Its Influence on the Lipid Parameters in Nonalcoholic Fatty Liver Disease Patients. Applied Sciences 2021; 11(13): 5836 doi: 10.3390/app11135836
|
| 39 |
Veronica Marin, Silvia Gazzin, Sabrina Gambaro, Matteo Dal Ben, Sonia Calligaris, Monica Anese, Alan Raseni, Claudio Avellini, Pablo Giraudi, Claudio Tiribelli, Natalia Rosso. Effects of Oral Administration of Silymarin in a Juvenile Murine Model of Non-alcoholic Steatohepatitis. Nutrients 2017; 9(9): 1006 doi: 10.3390/nu9091006
|
| 40 |
Mohammed Sikander, Shabnam Malik, Anyssa Rodriguez, Murali M. Yallapu, Acharan S. Narula, Sanjaya K. Satapathy, Vijian Dhevan, Subhash C. Chauhan, Meena Jaggi. Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction. Molecules 2020; 25(24): 5905 doi: 10.3390/molecules25245905
|
| 41 |
Wen-Long Sun, Sha Hua, Xin-Yu Li, Liang Shen, Hao Wu, Hong-Fang Ji. Microbially produced vitamin B12 contributes to the lipid-lowering effect of silymarin. Nature Communications 2023; 14(1) doi: 10.1038/s41467-023-36079-x
|
| 42 |
Abdo Mahli, Andreas Koch, Barbara Czech, Philipp Peterburs, Anja Lechner, Jutta Haunschild, Martina Müller, Claus Hellerbrand. Hepatoprotective effect of oral application of a silymarin extract in carbon tetrachloride-induced hepatotoxicity in rats. Clinical Phytoscience 2015; 1(1) doi: 10.1186/s40816-015-0006-z
|
| 43 |
Anis Ben Hsouna, Sabah Dhibi, Wissal Dhifi, Wissem Mnif, hmed Ben Nasr, Najla Hfaiedh. Chemical composition and hepatoprotective effect of essential oil fromMyrtus communisL. flowers against CCL4-induced acute hepatotoxicity in rats. RSC Advances 2019; 9(7): 3777 doi: 10.1039/C8RA08204A
|
| 44 |
John E. Poulos, Peter T. Kalogerinis, Valentin Milanov, Constantine T. Kalogerinis, Emanuel J. Poulos. The Effects of Vitamin E, Silymarin and Carnitine on the Metabolic Abnormalities Associated with Nonalcoholic Liver Disease. Journal of Dietary Supplements 2022; 19(3): 287 doi: 10.1080/19390211.2021.1874587
|
| 45 |
Brandon Perumpail, Andrew Li, Umair Iqbal, Sandy Sallam, Neha Shah, Waiyee Kwong, George Cholankeril, Donghee Kim, Aijaz Ahmed. Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD. Diseases 2018; 6(3): 80 doi: 10.3390/diseases6030080
|
| 46 |
Jung-Hyo Cho, Jong-Suk Lee, Hyeong-Geug Kim, Hye Won Lee, Zhigang Fang, Hyeok-Hee Kwon, Dong Woon Kim, Chang-Min Lee, Jin-Woo Jeong. Ethyl Acetate Fraction of Amomum villosum var. xanthioides Attenuates Hepatic Endoplasmic Reticulum Stress-Induced Non-Alcoholic Steatohepatitis via Improvement of Antioxidant Capacities. Antioxidants 2021; 10(7): 998 doi: 10.3390/antiox10070998
|
| 47 |
Priscila O. Barbosa, Melina O. Souza, Maraísa P.S. Silva, Gabrielly T. Santos, Marcelo E. Silva, Giovanna Bermano, Renata N. Freitas. Açaí (Euterpe oleracea Martius) supplementation improves oxidative stress biomarkers in liver tissue of dams fed a high-fat diet and increases antioxidant enzymes’ gene expression in offspring. Biomedicine & Pharmacotherapy 2021; 139: 111627 doi: 10.1016/j.biopha.2021.111627
|
| 48 |
Antonietta Stellavato, Anna Virginia Adriana Pirozzi, Francesca de Novellis, Ilaria Scognamiglio, Valentina Vassallo, Andrea Maria Giori, Mario De Rosa, Chiara Schiraldi. In vitro assessment of nutraceutical compounds and novel nutraceutical formulations in a liver-steatosis-based model. Lipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0663-2
|
| 49 |
Tuba Maryam, Nosheen Fatima Rana, Sultan M. Alshahrani, Farhat Batool, Misha Fatima, Tahreem Tanweer, Salma Saleh Alrdahe, Yasmene F. Alanazi, Ifat Alsharif, Fatima S. Alaryani, Amer Sohail Kashif, Farid Menaa. Silymarin Encapsulated Liposomal Formulation: An Effective Treatment Modality against Copper Toxicity Associated Liver Dysfunction and Neurobehavioral Abnormalities in Wistar Rats. Molecules 2023; 28(3): 1514 doi: 10.3390/molecules28031514
|
| 50 |
Ludovico Abenavoli, Angelo A. Izzo, Natasa Milić, Carla Cicala, Antonello Santini, Raffaele Capasso. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytotherapy Research 2018; 32(11): 2202 doi: 10.1002/ptr.6171
|
| 51 |
Nancy Vargas-Mendoza, Eduardo Madrigal-Santillán, Ángel Morales-González, Jaime Esquivel-Soto, Cesar Esquivel-Chirino, Manuel García-Luna y González-Rubio, Juan A Gayosso-de-Lucio, José A Morales-González. Hepatoprotective effect of silymarin. World Journal of Hepatology 2014; 6(3): 144-149 doi: 10.4254/wjh.v6.i3.144
|
| 52 |
Asal Sarrafan, Maryam Ghobeh, Parichehreh Yaghmaei. The effect of 6-gingerol on biochemical and histological parameters in cholesterol-induced nonalcoholic fatty liver disease in NMRI mice. Brazilian Journal of Pharmaceutical Sciences 2021; 57 doi: 10.1590/s2175-979020200003181020
|
| 53 |
Eun-Jung Park, You-Suk Lee, Sung Min Kim, Gun-Seok Park, Yong Hyun Lee, Do Yeun Jeong, Jihee Kang, Hae-Jeung Lee. Beneficial Effects of Lactobacillus plantarum Strains on Non-Alcoholic Fatty Liver Disease in High Fat/High Fructose Diet-Fed Rats. Nutrients 2020; 12(2): 542 doi: 10.3390/nu12020542
|
| 54 |
Gianni Testino, Silvia Leone, Sharmila Fagoonee, Rinaldo Pellicano. Alcoholic liver fibrosis: detection and treatment. Minerva Medica 2018; 109(6) doi: 10.23736/S0026-4806.18.05844-5
|
| 55 |
Fang Liu, Meng Wang, Yang Wang, Yiwei Cao, Zhaolin Sun, Mingcang Chen, Xiaoting Tian, Jianbo Wan, Chenggang Huang. Metabonomics Study on the Hepatoprotective Effect of Panax notoginseng Leaf Saponins Using UPLC/Q-TOF-MS Analysis. The American Journal of Chinese Medicine 2019; 47(03): 559 doi: 10.1142/S0192415X19500290
|
| 56 |
Faezeh Abbasirad, Vahid Shaygannejad, Fahimeh Hosseininasab, Omid Mirmosayyeb, Behzad Mahaki, Behjat Moayedi, Nafiseh Esmaeil. Significant immunomodulatory and hepatoprotective impacts of Silymarin in MS patients: A double-blind placebo-controlled clinical trial. International Immunopharmacology 2021; 97: 107715 doi: 10.1016/j.intimp.2021.107715
|
| 57 |
Masoumeh Akhlaghi. Non-alcoholic Fatty Liver Disease: Beneficial Effects of Flavonoids. Phytotherapy Research 2016; 30(10): 1559 doi: 10.1002/ptr.5667
|
| 58 |
Annalisa Curcio, Adriana Romano, Simona Cuozzo, Antonio Di Nicola, Orazio Grassi, Donatella Schiaroli, Giuseppe Fabrizio Nocera, Michele Pironti. Silymarin in Combination with Vitamin C, Vitamin E, Coenzyme Q10 and Selenomethionine to Improve Liver Enzymes and Blood Lipid Profile in NAFLD Patients. Medicina 2020; 56(10): 544 doi: 10.3390/medicina56100544
|
| 59 |
Francesca Maria Trovato, Daniela Catalano, Giuseppe Musumeci, Guglielmo M Trovato. 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine—recommendations for facing obesity, fatty liver and fibrosis epidemics. EPMA Journal 2014; 5(1) doi: 10.1186/1878-5085-5-21
|
| 60 |
Naza Jalal Awla, Alaadin M. Naqishbandi, Younis Baqi. Preventive and Therapeutic Effects of Silybum marianum Seed Extract Rich in Silydianin and Silychristin in a Rat Model of Metabolic Syndrome. ACS Pharmacology & Translational Science 2023; 6(11): 1715 doi: 10.1021/acsptsci.3c00171
|
| 61 |
Maria Del Ben, Licia Polimeni, Francesco Baratta, Daniele Pastori, Francesco Angelico. The role of nutraceuticals for the treatment of non‐alcoholic fatty liver disease. British Journal of Clinical Pharmacology 2017; 83(1): 88 doi: 10.1111/bcp.12899
|
| 62 |
|
| 63 |
Adnan Malik, Muhammad Malik, Shahbaz Qureshi. Effects of silymarin use on liver enzymes and metabolic factors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis. Canadian Liver Journal 2024; 7(1): 40 doi: 10.3138/canlivj-2023-0021
|
| 64 |
Beniamino PALMIERI, Veronica CORAZZARI, Diana G. PANARIELLO BRASILE, Vincenzo SANGIOVANNI, Maria VADALÀ. Hepatic steatosis integrated approach: nutritional guidelines and joined nutraceutical administration. Minerva Gastroenterologica e Dietologica 2021; 66(4) doi: 10.23736/S1121-421X.20.02738-5
|
| 65 |
Alper Sonmez, Cemal Nuri Ercin, Mustafa Cesur, Teoman Dogru. Nutraceuticals and Cardiovascular Disease. Contemporary Cardiology 2021; : 141 doi: 10.1007/978-3-030-62632-7_9
|
| 66 |
Masoumeh Asgarshirazi, Mamak Shariat, Mahdi Sheikh. Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial. Hepatobiliary & Pancreatic Diseases International 2017; 16(3): 296 doi: 10.1016/S1499-3872(16)60142-X
|
| 67 |
Guoyan Jiang, Chunhong Sun, Xiaodong Wang, Jie Mei, Chen Li, Honghong Zhan, Yixuan Liao, Yongjun Zhu, Jingxin Mao. Hepatoprotective mechanism of Silybum marianum on nonalcoholic fatty liver disease based on network pharmacology and experimental verification. Bioengineered 2022; 13(3): 5216 doi: 10.1080/21655979.2022.2037374
|
| 68 |
Samarth Siddharth Patel, Mohammad Shadab Siddiqui. Current and Emerging Therapies for Non-alcoholic Fatty Liver Disease. Drugs 2019; 79(1): 75 doi: 10.1007/s40265-018-1040-1
|
| 69 |
Maryam Vahabzadeh, Nafise Amiri, Gholamreza Karimi. Effects of silymarin on metabolic syndrome: a review. Journal of the Science of Food and Agriculture 2018; 98(13): 4816 doi: 10.1002/jsfa.9115
|
| 70 |
Ludovico Abenavoli, Valentina Peta, Natasa Milic. Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: a case series. Annals of Hepatology 2015; 14(1): 121 doi: 10.1016/S1665-2681(19)30809-9
|
| 71 |
Shiv Chitturi, Vincent Wai‐Sun Wong, Wah‐Kheong Chan, Grace Lai‐Hung Wong, Simon Kin‐Hung Wong, Jose Sollano, Yen‐Hsuan Ni, Chun‐Jen Liu, Yu‐Cheng Lin, Laurentius Adrianto Lesmana, Seung Up Kim, Etsuko Hashimoto, Masahide Hamaguchi, Khean‐Lee Goh, Jiangao Fan, Ajay Duseja, Yock Young Dan, Yogesh Chawla, Geoff Farrell, Henry Lik‐Yuen Chan. The Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 2: Management and special groups. Journal of Gastroenterology and Hepatology 2018; 33(1): 86 doi: 10.1111/jgh.13856
|
| 72 |
Wonjong Lee, Dong Gun Lee. Potential role of potassium and chloride channels in regulation of silymarin‐induced apoptosis in Candida albicans. IUBMB Life 2018; 70(3): 197 doi: 10.1002/iub.1716
|
| 73 |
Francesca M. Trovato, Daniela Catalano, Giuseppe F. Martines, Guglielmo M. Trovato. Coffee in Health and Disease Prevention. 2015; : 567 doi: 10.1016/B978-0-12-409517-5.00064-4
|
| 74 |
Fariba Aghaei, Alexei Wong, Mehdi Zargani, Amir Sarshin, Foad Feizolahi, Zhila Derakhshan, Mohammadreza Hashemi, Ehsan Arabzadeh. Effects of swimming exercise combined with silymarin and vitamin C supplementation on hepatic inflammation, oxidative stress, and histopathology in elderly rats with high-fat diet-induced liver damage. Nutrition 2023; 115: 112167 doi: 10.1016/j.nut.2023.112167
|
| 75 |
Jia Xiao, Feiyue Xing, Jie Huo, Man Lung Fung, Emily C. Liong, Yick Pang Ching, Aimin Xu, Raymond Chuen Chung Chang, Kwok Fai So, George L. Tipoe. Lycium barbarum polysaccharides therapeutically improve hepatic functions in non-alcoholic steatohepatitis rats and cellular steatosis model. Scientific Reports 2014; 4(1) doi: 10.1038/srep05587
|
| 76 |
Devaraj Ezhilarasan. Phytochemicals as Lead Compounds for New Drug Discovery. 2020; : 195 doi: 10.1016/B978-0-12-817890-4.00012-3
|
| 77 |
Jeongeun Mun, Shintae Kim, Ho-Geun Yoon, Yanghee You, Ok-Kyung Kim, Kyung-Chul Choi, Yoo-Hyun Lee, Jeongmin Lee, Jeongjin Park, Woojin Jun. Water Extract of Curcuma longa L. Ameliorates Non-Alcoholic Fatty Liver Disease. Nutrients 2019; 11(10): 2536 doi: 10.3390/nu11102536
|
| 78 |
Tingting Shi, Li Wu, Wenjun Ma, Liping Ju, Minghui Bai, Xiaowei Chen, Shourong Liu, Xingxin Yang, Junping Shi. Nonalcoholic Fatty Liver Disease: Pathogenesis and Treatment in Traditional Chinese Medicine and Western Medicine. Evidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/8749564
|